DA Davidson resumed coverage on Nature's Sunshine with a new price target
$NATR
Biotechnology: Pharmaceutical Preparations
Health Care
DA Davidson resumed coverage of Nature's Sunshine with a rating of Buy and set a new price target of $19.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/7/2025 | $19.00 | Buy | DA Davidson |
| 9/13/2024 | $18.00 | Buy | Canaccord Genuity |
| 3/9/2022 | $24.00 → $24.50 | Buy | DA Davidson |
| 11/5/2021 | $22.00 → $24.00 | Buy | DA Davidson |
| 10/15/2021 | $22.00 | Buy | DA Davidson |